These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23172264)

  • 21. Effects of prednisone on the International Normalized Ratio.
    Stading JA; Chock A; Faulkner MA; Skrabal MZ
    Am J Health Syst Pharm; 2006 Dec; 63(23):2354-6. PubMed ID: 17106008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Telaprevir is effective given every 8 or 12 hours with ribavirin and peginterferon alfa-2a or -2b to patients with chronic hepatitis C.
    Marcellin P; Forns X; Goeser T; Ferenci P; Nevens F; Carosi G; Drenth JP; Serfaty L; De Backer K; Van Heeswijk R; Luo D; Picchio G; Beumont M
    Gastroenterology; 2011 Feb; 140(2):459-468.e1; quiz e14. PubMed ID: 21034744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telaprevir alone or with peginterferon and ribavirin reduces HCV RNA in patients with chronic genotype 2 but not genotype 3 infections.
    Foster GR; Hézode C; Bronowicki JP; Carosi G; Weiland O; Verlinden L; van Heeswijk R; van Baelen B; Picchio G; Beumont M
    Gastroenterology; 2011 Sep; 141(3):881-889.e1. PubMed ID: 21699786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A small percentage of patients with hepatitis C receive triple therapy with boceprevir or telaprevir.
    Chen EY; Sclair SN; Czul F; Apica B; Dubin P; Martin P; Lee WM
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1014-20.e1-2. PubMed ID: 23602817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapy with boceprevir or telaprevir in HIV/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation.
    Antonini TM; Furlan V; Teicher E; Haim-Boukobza S; Sebagh M; Coilly A; Bonhomme-Faivre L; Roque-Afonso AM; Vittecoq D; Samuel D; Taburet AM; Duclos-Vallée JC
    AIDS; 2015 Jan; 29(1):53-8. PubMed ID: 25387314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pilot study of triple therapy with telaprevir, peginterferon and ribavirin for elderly patients with genotype 1 chronic hepatitis C.
    Hara T; Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Kumada H
    J Med Virol; 2013 Oct; 85(10):1746-53. PubMed ID: 23861088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated International Normalized Ratio associated with concurrent use of sorafenib and warfarin.
    Moretti LV; Montalvo RO
    Am J Health Syst Pharm; 2009 Dec; 66(23):2123-5. PubMed ID: 19923313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus NS3 protease genotyping and drug concentration determination during triple therapy with telaprevir or boceprevir for chronic infection with genotype 1 viruses, southeastern France.
    Aherfi S; Solas C; Motte A; Moreau J; Borentain P; Mokhtari S; Botta-Fridlund D; Dhiver C; Portal I; Ruiz JM; Ravaux I; Bregigeon S; Poizot-Martin I; Stein A; Gérolami R; Brouqui P; Tamalet C; Colson P
    J Med Virol; 2014 Nov; 86(11):1868-76. PubMed ID: 25052594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated International Normalized Ratio after concurrent ingestion of cranberry sauce and warfarin.
    Mergenhagen KA; Sherman O
    Am J Health Syst Pharm; 2008 Nov; 65(22):2113-6. PubMed ID: 18997138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: a multicenter experience.
    Coilly A; Roche B; Dumortier J; Leroy V; Botta-Fridlund D; Radenne S; Pageaux GP; Si-Ahmed SN; Guillaud O; Antonini TM; Haïm-Boukobza S; Roque-Afonso AM; Samuel D; Duclos-Vallée JC
    J Hepatol; 2014 Jan; 60(1):78-86. PubMed ID: 23994384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated international normalized ratio associated with concomitant warfarin and erlotinib.
    Thomas KS; Billingsley A; Amarshi N; Nair BA
    Am J Health Syst Pharm; 2010 Sep; 67(17):1426-9. PubMed ID: 20720241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated international normalized ratio values associated with concomitant use of warfarin and ceftriaxone.
    Clark TR; Burns S
    Am J Health Syst Pharm; 2011 Sep; 68(17):1603-5. PubMed ID: 21856805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Telaprevir for retreatment of HCV infection.
    Zeuzem S; Andreone P; Pol S; Lawitz E; Diago M; Roberts S; Focaccia R; Younossi Z; Foster GR; Horban A; Ferenci P; Nevens F; Müllhaupt B; Pockros P; Terg R; Shouval D; van Hoek B; Weiland O; Van Heeswijk R; De Meyer S; Luo D; Boogaerts G; Polo R; Picchio G; Beumont M;
    N Engl J Med; 2011 Jun; 364(25):2417-28. PubMed ID: 21696308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated International Normalized Ratio associated with concurrent use of ophthalmic erythromycin and warfarin.
    Parker DL; Hoffmann TK; Tucker MA; Gerschutz GP; Malone PM
    Am J Health Syst Pharm; 2010 Jan; 67(1):38-41. PubMed ID: 20044367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of telaprevir-containing triple therapy in the treatment of chronic hepatitis C in hemodialysed patients.
    Kaya S; Aksoz S; Baysal B; Ay N; Danis R
    Infect Dis (Lond); 2015 Sep; 47(9):658-61. PubMed ID: 25936530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of genotype 2 and 3 hepatitis C virus variants in patients treated with telaprevir demonstrates a consistent resistance profile across genotypes.
    De Meyer S; Ghys A; Foster GR; Beumont M; Van Baelen B; Lin TI; Dierynck I; Ceulemans H; Picchio G
    J Viral Hepat; 2013 Jun; 20(6):395-403. PubMed ID: 23647956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated international normalized ratio associated with use of dronedarone and warfarin.
    Pogge EK; Haber SL
    Ann Pharmacother; 2011 Sep; 45(9):e46. PubMed ID: 21811004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Possible warfarin interaction with menthol cough drops.
    Kassebaum PJ; Shaw DL; Tomich DJ
    Ann Pharmacother; 2005 Feb; 39(2):365-7. PubMed ID: 15644472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction between gemfibrozil and warfarin: case report and review of the literature.
    Dixon DL; Williams VG
    Pharmacotherapy; 2009 Jun; 29(6):744-8. PubMed ID: 19476425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated International Normalized Ratio values in a patient receiving warfarin and ceftaroline.
    Farhat NM; Hutchinson LS; Peters M
    Am J Health Syst Pharm; 2016 Jan; 73(2):56-9. PubMed ID: 26721534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.